IMVT
IMVT
US45258J1025
Immunovant, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
6.29B EUR
7.95B EUR
5.07B EUR
5.17B EUR
Enterprise Value
5.45B EUR
7.15B EUR
4.16B EUR
4.17B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-11.08x
--
--
--
Price to Sales
--
--
--
--
Price to Book
8.55x
10.81x
5.94x
5.24x
EV/Revenue
--
--
--
--
EV/EBITDA
-9.64x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-3.79%
-5.21%
-8.04%
-6.04%
ende